Trial Status: 
Legacy Trial - NOT IN USE, use "Closed"

A Multi-Center, Randomized, Controlled, Double-Blind Study of the Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Patients 


The purpose of this study in Cystic Fibrosis will be to further evaluate the effects of a modified formulation of AquADEKs® (AquADEKs-2) on markers of inflammation, antioxidant levels, and oxidative stress.


You may be eligible if you are over 12 years of age, have cystic fibrosis, and have pancreatic insufficiency.


Cystic Fibrosis Foundation Therapeutics

Principal Investigator: 

Cori Daines, MD

Contact Information:

Osmara Y. Molina de Rodriguez, MS

Cell: (520) 891-6767 or Office: (520) 626-3910


Principal Investigator: 
Research Area: 
Clinical and Population Research